Published in J Immunol on December 15, 1997
Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity (2009) 3.51
Hypoxia-inducible factors 1 and 2 are important transcriptional effectors in primary macrophages experiencing hypoxia. Blood (2009) 1.70
Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice. J Virol (2011) 1.61
Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A (1999) 1.50
Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One (2009) 1.02
Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc Natl Acad Sci U S A (1998) 1.02
IL-1β is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol (2011) 1.01
Decoys and Regulatory "Receptors" of the IL-1/Toll-Like Receptor Superfamily. Front Immunol (2013) 0.96
Induction of uteroglobin-related protein 2 (Ugrp2) gene expression by the Th2 cytokines IL-4 and IL-13. J Immunol (2005) 0.92
Microarray studies on effects of Pneumocystis carinii infection on global gene expression in alveolar macrophages. BMC Microbiol (2010) 0.86
TCR Valpha14 natural killer T cells function as effector T cells in mice with collagen-induced arthritis. Clin Exp Immunol (2005) 0.85
Genetic polymorphisms and the risk of infection following esophagectomy. positive association with TNF-alpha gene -308 genotype. Ann Surg (2007) 0.82
Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery. J Pain (2013) 0.80
Cytokine decoy and scavenger receptors as key regulators of immunity and inflammation. Cytokine (2016) 0.76
IFN-gamma down-regulates Secretoglobin 3A1 gene expression. Biochem Biophys Res Commun (2009) 0.76
The inflammasome: an emerging therapeutic oncotarget for cancer prevention. Oncotarget (2016) 0.76
Interleukin-10 inhibits expression of both interferon alpha- and interferon gamma- induced genes by suppressing tyrosine phosphorylation of STAT1. Blood (1999) 1.88
Cloning, expression and initial characterization of interleukin-19 (IL-19), a novel homologue of human interleukin-10 (IL-10). Genes Immun (2000) 1.58
Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A (1999) 1.50
Identification, cloning, and characterization of a novel soluble receptor that binds IL-22 and neutralizes its activity. J Immunol (2001) 1.35
Inhibition of IL-12 production in human monocyte-derived macrophages by TNF. J Immunol (2000) 1.30
IL-4 reciprocally regulates IL-1 and IL-1 receptor antagonist expression in human monocytes. J Immunol (1992) 1.22
Production of IL-10 by human natural killer cells stimulated with IL-2 and/or IL-12. J Immunol (1998) 1.20
Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling. Genes Immun (2006) 1.11
Interleukin-10 inhibits interferon-gamma-induced intercellular adhesion molecule-1 gene transcription in human monocytes. Blood (1997) 1.08
IFN-gamma priming of monocytes enhances LPS-induced TNF production by augmenting both transcription and MRNA stability. Cytokine (1995) 1.07
Immunosuppression induced by staphylococcal enterotoxin B. Cell Immunol (1982) 1.00
Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J Leukoc Biol (1999) 0.99
Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells. J Viral Hepat (2012) 0.97
Differential responses of human monocytes and macrophages to IL-4 and IL-13. J Leukoc Biol (1999) 0.95
Partial restoration of impaired interleukin-2 production and Tac antigen (putative interleukin-2 receptor) expression in patients with acquired immune deficiency syndrome by isoprinosine treatment in vitro. J Clin Invest (1985) 0.93
Interleukin-10 upregulates tumor necrosis factor receptor type-II (p75) gene expression in endotoxin-stimulated human monocytes. Blood (1997) 0.89
Specificity of anti-lymphocyte antibodies in sera from patients with AIDS-related complex (ARC) and healthy homosexuals. Clin Exp Immunol (1988) 0.87
Lymphokine-independent induction of macrophage membrane IL-1 by autoreactive T cells recognizing either class I or class II MHC determinants. J Immunol (1988) 0.87
Involvement of the IL-2 receptor gamma-chain (gammac) in the control by IL-4 of human monocyte and macrophage proinflammatory mediator production. J Immunol (1998) 0.84
Interleukin-12 differentially regulates expression of IFN-gamma and interleukin-2 in human T lymphoblasts. J Interferon Cytokine Res (2000) 0.84
Inhibition of interleukin-2-induced T-cell proliferation by sera from patients with the acquired immune deficiency syndrome. J Clin Immunol (1986) 0.84
Inhibitors of prostaglandin synthesis block the induction of staphylococcal enterotoxin B-activated T-suppressor cells. Cell Immunol (1983) 0.79
Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6. Eur J Immunol (1999) 0.79
Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressor (PITS). II. Resolution of multiple PITS beta factors. Cell Immunol (1984) 0.78
Intraspinal cholesteatoma. J Neurosurg Nurs (1981) 0.75
Suppression of B-cell and T-cell responses by the prostaglandin-induced T-cell-derived suppressors (PITS)--III. Production of PITS beta factors from T-cell hybridomas. Int J Immunopharmacol (1985) 0.75
Isoprinosine effects on interleukin-1 production in acquired immune deficiency syndrome (AIDS). Int J Immunopharmacol (1986) 0.75
Kinetic analysis of the immunopotentiating effect of the hypoxanthine analogue, NPT-15392, on the interleukin-2 production potential of human lymphocytes. Int J Immunopharmacol (1986) 0.75
Motor pool organization of the external gastrocnemius muscle in the turtle, Pseudemys (Trachemys) scripta elegans. J Morphol (1996) 0.75